METHOD FOR ASSESSING RISK OF PROGRESSIVE COURSE OF OBLITERATING ARTERIAL SCLEROSIS OF LOWER EXTREMITIES Russian patent published in 2016 - IPC G01N33/48 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to surgery, and can be used for assessing of progressing obliterating arterial sclerosis of lower extremities risk in following 6 months. Method: monocyte index is taken into account, wherein the monocyte index less than 5 is estimated as 1 point, equal to or more than 5-0 points; taking into account atherogenicity index, the atherogenicity index less than 5 evaluated as 0 points, equal to or more than 5-2 points; considered total homo cystein, at level of total homo cystein less than 15 mcmol/l evaluated as 0 points, equal to 15 mcmol/l and less than or equal to 30 mcmol/l-1 point, more than 30 mcmol/l-2 points; other factors are allowed for progressing atherosclerosis, the use of statins in integrated treatment of atherosclerosis evaluated as 0 points, without receiving statins feature is evaluated as 2 points, all evaluated as 2 points, giving up of smoking for 11 months and more as 0 points. Then points are summed up, if amount of 6 points and more then high risk of atherosclerosis of lower extremities is probable.

EFFECT: invention provides integrated assessment of risk factors, enables assessing of obliterating arterial sclerosis of lower extremities risk in following 6 months, and if necessary to correct lipid-lowering and vasodilatatory therapy and timely assess necessity of surgical interventions.

1 cl, 5 tbl, 3 ex